Vedolizumab Therapy for Ulcerative Colitis and Crohn’s Disease | Now@NEJM

Retweeted NEJM (@NEJM): Now@NEJM reports on two new trials of vedolizumab; one for Crohn’s Disease and one for Ulcerative Colitis. http://t.co/UorKqTOijY

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/UorKqTOijY